Alendronate
Product Images NDC 10135-696

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Alendronate (NDC 10135-696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Molecular Formula Of Alendronate Sodium Is C4h12nnao7p2•3h2o And Its Formula Weight Is325.12. The Structural Formula Is: (Alendronate Sodium Tablets 01)

Chemical structure diagram of Alendronate showing its molecular composition, including phosphate groups, side chains, and hydration as a trihydrate form (3H2O). The diagram includes sodium (Na) and functional groups such as hydroxyl and amino groups.*

FDA Label Image

Figure 1:cumulative Incidence Of Hip Fractures In The Three-year Study Of Fit (patients With Radiographic Vertebral Fracture At Baseline) (Alendronate Sodium Tablets 02)

A line graph comparing cumulative incidence percentages over time in months for Alendronate Sodium versus placebo. The x-axis represents time up to 36 months, and the y-axis shows cumulative incidence from 0 to 10%. Two lines depict outcomes: a solid line for Alendronate Sodium and a dashed line for placebo.*

FDA Label Image

Figure 2: Osteoporosis Treatment Studies In Postmenopausal Womenincrease In Bmd Alendronate 10 mg/day At Three Years (Alendronate Sodium Tablets 03)

Bar chart comparing mean percentage increase in bone mineral density (BMD) relative to placebo with standard error at three anatomical sites: lumbar spine, femoral neck, and trochanter, for two groups labeled USA and Multinational. The vertical axis shows BMD increase percentage, and error bars indicate variability in measurements.*

FDA Label Image

Figure 3: Figure 3: Osteoporosis Treatment Studies In Postmenopausal Womentime Course Of Effect Of Alendronate 10 mg/day Versus Placebo: Lumbar Spine Bmd Percent Change From Baseline (Alendronate Sodium Tablets 04)

Two line graphs titled US Study and Multinational Study showing bone mineral density (BMD) mean percentage change from baseline over 36 months. Both compare Alendronate Sodium 10 mg and placebo, with Alendronate showing a steady increase in BMD, while placebo remains near baseline.*

FDA Label Image

Figure 4 (Alendronate Sodium Tablets 05)

Two bar graphs showing the change in bone mineral density (BMD) from baseline over 2-year and 3-year studies. The graphs compare mean percentage BMD changes with Alendronate Sodium 5 mg/day versus placebo across four body sites: lumbar spine, femoral neck, trochanter, and total body.*

FDA Label Image

Figure 5 (Alendronate Sodium Tablets 06)

A bar chart illustrating the increase in bone mineral density (BMD) over one year in glucocorticoid-treated patients taking Alendronate 5 mg/day. The chart compares mean percentage BMD increases relative to placebo for U.S. and multinational populations across three anatomical sites: lumbar spine, femoral neck, and trochanter, with error bars representing standard error.*

FDA Label Image

Figure 6: (Alendronate Sodium Tablets 07)

A line graph displaying the effect of Alendronate 40 mg/day, Etidronate 400 mg/day, and placebo on serum alkaline phosphatase levels in Paget's disease of bone. The y-axis shows percent change from baseline serum alkaline phosphatase, and the x-axis shows time in months up to 6 months. Data is presented for two Alendronate 40 mg/day studies (multinational and U.S.) compared to placebo and Etidronate, with Alendronate groups showing greater reductions over time.*

FDA Label Image

Principal Display Panel- 35 mg Tablet Blister Pack Carton4 Tabletsrx Onlyndc 10135-0696-44once Weekly (Alendronate Sodium Tablets 08)

Alendronate Sodium Tablets, USP 35 mg carton label from Marlex Pharmaceuticals Inc. The label states the product is provided in a package of 4 tablets for once weekly use. The front panel includes the brand and generic names, strength, dosage form, directions to apply a prescription label, and storage information. Manufacturer details and usage instructions are also printed on the label.*

FDA Label Image

Principal Display Panel- 35 mg Tablet Blister Pack Carton12 (3×4) Unit-of-us E Tabletsrx Onlyndc 10135-0696-12once Weekly (Alendronate Sodium Tablets 09)

Alendronate Sodium Tablets, USP 35 mg, once weekly dosage, by Marlex Pharmaceuticals Inc. The label shows a 12 (3x4) unit-of-use tablet pack with clear directions for weekly use. It includes manufacturer details from Marlex Pharmaceuticals, New Castle, DE, and storage instructions. The label also indicates the prescription status and dosage form as tablets.*

FDA Label Image

Principal Display Panel- 70 mg Tablet Blister Pack Carton4 Tabletsrx Onlyndc 10135-0697-44once Weekly (Alendronate Sodium Tablets 0a)

Packaging label for Alendronate Sodium Tablets, USP 70 mg by Marlex Pharmaceuticals Inc. The label states a weekly dosage with 4 tablets in the package. The design includes dosage details, directions summary, labeler information, and a barcode. The product name and strength are prominently displayed.*

FDA Label Image

Principal Display Panel- 70 mg Tablet Blister Pack Carton12 (3×4) Unit-of-use Tabletsrx Onlyndc 10135-0697-12 Once Weekly (Alendronate Sodium Tablets 0b)

Packaging label for Alendronate Sodium Tablets, USP 70 mg, by Marlex Pharmaceuticals Inc. The label indicates the tablets are once weekly dosage, in a 12-count (3x4) unit-of-use package. The label includes directions for use, storage information, and space for a prescription label. It is primarily white with blue and red text and design elements.*

FDA Label Image

Principal Display Panel- 70 mg Tablet Blister Pack Carton20 (2×10) Unit-dose Tabletsrx Onlyndc 10135-0697-20once Weekly (Alendronate Sodium Tablets 0c)

Packaging label for Alendronate Sodium Tablets, USP 70 mg by Marlex Pharmaceuticals Inc. The label indicates the tablets are for once weekly use, with 20 tablets per package (2x10 unit dose). Additional text includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.